Hyderabad: Serum Institute of India(SII) on April 28 announced the price of its Covid vaccine, Covishield has been reduced for the states from Rs 400 to Rs 300 per dose.
Adar Poonawalla, CEO of SII said that as a philanthropic gesture he is reducing the price of the vaccine. "As a philanthropic gesture on behalf of Serum Institute of India, I hereby reduce the price to the states from Rs 400 to Rs 300 per dose, effective immediately; this will save thousands of crores of state funds going forward. This will enable more vaccinations and save countless lives," said Adar Poonawala.
On April 21, SII announced that its COVID19 vaccine Covishield will be sold at Rs 400 a shot to states and Rs 600 to private hospitals, days ahead of the next phase of vaccinations from May 1 which will inoculate everyone above the age of 18. The pharma company will continue to sell vaccine doses to centres for Rs 150 each.
SII also said that it will sell the Covishield vaccine to private hospitals for Rs 600.
Meanwhile, The registration for Covid vaccination for all above 18 years of age began on Co-WIN portal and Aarogya Setu app from 4 pm Wednesday. However, high user traffic resulted in both the platforms crashing for a brief period. Both the platforms are working fine now.